Colgate-Palmolive Company vs Twist Bioscience Corp — how do they compare? Colgate-Palmolive Company trades at $91.08 (market cap $74.59B), while Twist Bioscience Corp trades at $93.17 (market cap $5.63B). The key difference: Colgate-Palmolive Company is far larger — about 13.2× Twist Bioscience Corp's market cap, and Colgate-Palmolive Company pays a 2.27% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| CL | TWST | |
|---|---|---|
Market Cap | $74.59B | $5.63B |
Sector | Consumer Staples | Health |
52-Week High | $99.14 | $102.88 |
52-Week Low | $74.98 | $24.16 |
Enterprise Value | $81.22B | $5.55B |
Dividend Yield | 2.27% | — |
Trailing returns across standard periods
Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries (international sales account for about 70% of its consolidated total, including approximately 45% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.
Read more on CL →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →